Occurrence and clinical management of moderate-to-severe adverse events during drug-resistant tuberculosis treatment: a retrospective cohort study

door Sagwa, Evans L, Mantel-Teeuwisse, Aukje K, Ruswa, Nunurai C
Gepubliceerd in J Pharm Policy Pract (2014)

Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda

door Kibira, Denis, Kitutu, Freddy Eric, Merrett, Gemma Buckland, Mantel-Teeuwisse, Aukje K.
Gepubliceerd in J Pharm Policy Pract (2017)

Future of the European Union regulatory network in the context of the uptake of new medicines

door Hoebert, Joëlle M, Irs, Alar, Mantel-Teeuwisse, Aukje K, Leufkens, Hubert G M
Gepubliceerd in 2013

Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists

door Bazargani, Yaser T., de Boer, Anthonius, Leufkens, Hubert G. M., Mantel-Teeuwisse, Aukje K.
Gepubliceerd in 2014

Characteristics of drugs safety signals that predict safety related product information update

door Insani, Widya N., Pacurariu, Alexandra C., Mantel‐Teeuwisse, Aukje K., Gross‐Martirosyan, Liana
Gepubliceerd in Pharmacoepidemiol Drug Saf (2018)

The double opioid crisis: A call for balance

door Vranken, Marjolein J.M., Schutjens, Marie‐Hélène D.B., Mantel‐Teeuwisse, Aukje K.
Gepubliceerd in Pharmacoepidemiol Drug Saf (2019)

Systematic reviews of ten pharmaceutical pricing policies – a research protocol

door Tordrup, David, van den Ham, Hendrika A., Glanville, Julie, Mantel-Teeuwisse, Aukje K.
Gepubliceerd in J Pharm Policy Pract (2020)

Price changes of antibiotics and perceived substitutes in the context of OTC policy changes in Mexico and Brazil

door Santa-Ana-Tellez, Yared, Wirtz, Veronika J, Leufkens, Hubert GM, Mantel-Teeuwisse, Aukje K
Gepubliceerd in J Pharm Policy Pract (2015)

Five-year trends in treatment changes in an adult cohort of HIV/AIDS patients in Ghana: a retrospective cohort study

door Ankrah, Daniel N. A., Lartey, Margaret, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M.
Gepubliceerd in BMC Infect Dis (2017)

Essential Medicines Are More Available than Other Medicines around the Globe

door Bazargani, Yaser T., Ewen, Margaret, de Boer, Anthonius, Leufkens, Hubert G. M., Mantel-Teeuwisse, Aukje K.
Gepubliceerd in 2014

Seasonal Variation in Penicillin Use in Mexico and Brazil: Analysis of the Impact of Over-the-Counter Restrictions

door Santa-Ana-Tellez, Yared, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M., Wirtz, Veronika J.
Gepubliceerd in Antimicrob Agents Chemother (2014)

Reply to “Decrease in Penicillin Sales in Brazil after Over-the-Counter Restrictions”

door Santa-Ana-Tellez, Yared, Mantel-Teeuwisse, Aukje K., Leufkens, Hubert G. M., Wirtz, Veronika J.
Gepubliceerd in Antimicrob Agents Chemother (2015)

Recent trends in (under)treatment of hypercholesterolaemia in the Netherlands

door Mantel-Teeuwisse, Aukje K, Verschuren, W M Monique, Klungel, Olaf H, de Boer, Anthonius, Kromhout, Daan
Gepubliceerd in 2004

Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries

door Cameron, Alexandra, Roubos, Ilse, Ewen, Margaret, Mantel-Teeuwisse, Aukje K, Leufkens, Hubertus GM, Laing, Richard O
Gepubliceerd in 2011

National medicines policies – a review of the evolution and development processes

door Hoebert, Joëlle M, van Dijk, Liset, Mantel-Teeuwisse, Aukje K, Leufkens, Hubert GM, Laing, Richard O
Gepubliceerd in 2013

Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU

door Hoekman, Jarno, Klamer, Thea T., Mantel‐Teeuwisse, Aukje K., Leufkens, Hubert G. M., De Bruin, Marie L.
Gepubliceerd in Br J Clin Pharmacol (2016)

Adverse events and patients’ perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia

door Sagwa, Evans L, Ruswa, Nunurai, Mavhunga, Farai, Rennie, Timothy, Leufkens, Hubert GM, Mantel-Teeuwisse, Aukje K
Gepubliceerd in Patient Prefer Adherence (2016)

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study

door Jacobs, Tom G., Hilda Ampadu, H., Hoekman, Jarno, Dodoo, Alexander N. O., Mantel-Teeuwisse, Aukje K.
Gepubliceerd in BMC Public Health (2018)

Time trends in lipid lowering drug use in The Netherlands. Has the backlog of candidates for treatment been eliminated?

door Mantel-Teeuwisse, Aukje K, Klungel, Olaf H, Verschuren, W M Monique, Porsius, Arijan J, de Boer, Anthonius
Gepubliceerd in 2002

Regulatory scientific advice in drug development: does company size make a difference?

door Putzeist, Michelle, Mantel-Teeuwisse, Aukje K., Gispen-De Wied, Christine C., Hoes, Arno W., Leufkens, Hubert G.
Gepubliceerd in 2010